Literature DB >> 28542140

miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice.

Pedro M Rodrigues, Marta B Afonso, André L Simão, Catarina C Carvalho, Alexandre Trindade, António Duarte, Pedro M Borralho, Mariana V Machado, Helena Cortez-Pinto, Cecília Mp Rodrigues, Rui E Castro.   

Abstract

This corrects the article DOI: 10.1038/cddis.2017.172.

Entities:  

Year:  2017        PMID： 28542140      PMCID： PMC5520740          DOI： 10.1038/cddis.2017.246

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


Correction to: Cell Death and Disease (2017) 8, e2748; doi:10.1038/cddis.2017.172; published online 13 April 2017 Since the publication of this paper, it has been noted that Figure 1 was split to appear in two different pages resulting in panels (a)–(g) being displaced, rendering the figure incomprehensible. The figure has been reformatted to appear on one page. The corrected article appears online together with this erratum. The publishers apologize for any inconvenience this may have caused.
  5 in total

1.  Is miR-21 a potent target for liver fibrosis?

Authors:  Sanchuan Lai; Yasuko Iwakiri
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

2.  Osteocytic miR21 deficiency improves bone strength independent of sex despite having sex divergent effects on osteocyte viability and bone turnover.

Authors:  Hannah M Davis; Padmini J Deosthale; Rafael Pacheco-Costa; Alyson L Essex; Emily G Atkinson; Mohammad W Aref; Julian E Dilley; Teresita Bellido; Mircea Ivan; Matthew R Allen; Lilian I Plotkin
Journal:  FEBS J       Date:  2019-10-08       Impact factor: 5.542

Review 3.  microRNA-based diagnostic and therapeutic applications in cancer medicine.

Authors:  Lorenzo F Sempere; Asfar S Azmi; Anna Moore
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-05-17       Impact factor: 9.957

Review 4.  Current and Future Treatments in the Fight Against Non-Alcoholic Fatty Liver Disease.

Authors:  Benoit Smeuninx; Ebru Boslem; Mark A Febbraio
Journal:  Cancers (Basel)       Date:  2020-06-28       Impact factor: 6.639

Review 5.  The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis.

Authors:  Nahum Méndez-Sánchez; Alejandro Valencia-Rodríguez; Carlos Coronel-Castillo; Alfonso Vera-Barajas; Jocelyn Contreras-Carmona; Guadalupe Ponciano-Rodríguez; Daniel Zamora-Valdés
Journal:  Ann Transl Med       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.